Published in N Engl J Med on May 20, 1976
Growth and hormonal status of children treated for acute lymphoblastic leukaemia. Arch Dis Child (1978) 1.19
Cancer, chemotherapy, and fertility. Br Med J (Clin Res Ed) (1985) 0.98
Abnormalities of growth and gonadal function in children treated for malignant disease: a review. J R Soc Med (1982) 0.96
Gonadal dysfunction after treatment of intracranial tumours. Arch Dis Child (1988) 0.91
Current issues in the management of children with acute lymphocytic leukaemia. Postgrad Med J (1985) 0.83
Chemotherapy and the adult gonad: a review. J R Soc Med (1983) 0.81
Dexrazoxane abrogates acute doxorubicin toxicity in marmoset ovary. Biol Reprod (2015) 0.78
Menstrual dysfunction in pathophysiologic states. West J Med (1985) 0.78
Treatment of childhood cancer: effects on the gonads. Br Med J (1978) 0.75
Childhood acute lymphoblastic leukaemia: a review. J R Soc Med (1982) 0.75
The price of survival in childhood leukaemia. Br Med J (1978) 0.75
The transformation of column-purified lymphocytes with nonspecific and specific antigenic stimuli. J Immunol (1968) 4.24
Production of antisera with small doses of immunogen: multiple intradermal injections. Methods Enzymol (1981) 3.37
Skeletal disease in primary hyperparathyroidism. J Bone Miner Res (1989) 3.00
A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol (1972) 2.76
Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med (1973) 2.30
Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 2.11
Osteoporosis and low bone mass in premenopausal and perimenopausal women. Endocr Pract (2001) 1.81
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis. Osteoporos Int (2010) 1.69
Gonadotropins and their subunits: basic and clinical studies. Recent Prog Horm Res (1976) 1.66
Enzymatic radioiodination of gonadotropins. J Clin Endocrinol Metab (1972) 1.61
The optic nerve as the site of initial relapse in childhood acute lymphoblastic leukemia. Cancer (1989) 1.55
Response of NZB and NZB-NZW spleen cells to mitogenic agents. J Immunol (1970) 1.54
Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med (1990) 1.39
Possible mechanism for Mycoplasma inhibition of lymphocyte transformation induced by phytohaemagglutinin. Nature (1968) 1.37
Varied manifestations of a familial lymphoproliferative disorder. Am J Med (1975) 1.29
L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med (1969) 1.29
Estrogen and follicle stimulation hormone interactions on follicle growth in rats. Endocrinology (1972) 1.27
Long-term second remissions in acute lymphatic leukemia. Cancer (1975) 1.27
Immune reactivity of leukemia patients to autologous blast cells. Cancer Res (1972) 1.24
Polycystic-ovary syndrome--what is it? N Engl J Med (1983) 1.20
Properties of the subunits of human chorionic gonadotropin. Endocrinology (1974) 1.18
Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma. N Engl J Med (1980) 1.18
Changing placental concentrations of human chorionic gonadotropin and its subunits during gestation. J Clin Endocrinol Metab (1974) 1.18
Glucocorticoid-binding proteins in human acute lymphoblastic leukemic blast cells. J Clin Invest (1973) 1.17
Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood (1993) 1.16
2,3-Dimercaptosuccinic acid as an antidote for lead intoxication. Clin Pharmacol Ther (1985) 1.15
Predictors of falls among postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2008) 1.15
Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. J Clin Oncol (1990) 1.14
Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol (1986) 1.08
A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group. Am J Med (1999) 1.08
Effects of inhibition of ribosomal RNA synthesis on the stimulation of lymphocytes by phytohaemagglutinin. Exp Cell Res (1969) 1.07
Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int (2012) 1.07
Irradiation, methotrexate toxicity, and the treatment of meningeal leukaemia. Lancet (1973) 1.06
Graft-versus-host disease. Morphologic variation and differential diagnosis in 8 cases of HL-A matched bone marrow transplantation. Am J Pathol (1971) 1.06
Immunological and biological activity of HCG following progressive desialylation. Endocrinology (1971) 1.06
Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study. Osteoporos Int (2007) 1.06
Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2007) 1.05
Beyond bone mineral density: can existing clinical risk assessment instruments identify women at increased risk of osteoporosis? J Intern Med (2004) 1.05
An acute-leukemia antigen: correlation with clinical status. N Engl J Med (1972) 1.04
A clinical approach to diagnosis and management of Paget's disease of bone. J Bone Miner Res (2001) 1.04
Intermittent high dose corticosteroid treatment in childhood cancer: behavioral and emotional consequences. J Am Acad Child Psychiatry (1986) 1.03
Bisphosphonates and iritis. Lancet (1993) 1.03
Graft-versus-host reaction complicating HL-A matched bone-marrow transplantation. Lancet (1970) 1.01
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int (2013) 1.00
Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine. Endocrinology (1988) 1.00
Reproductive endocrine disorders in men with partial seizures of temporal lobe origin. Arch Neurol (1986) 1.00
The in vivo behavior of human chorionic gonadotropin after dissociation into subunits. Endocrinology (1972) 0.99
Glycoprotein-hormone alpha-chain production by pancreatic endocrine tumors: a specific marker for malignancy. Immunocytochemical analysis of tumors of 155 patients. Cancer (1983) 0.99
An approach for identifying postmenopausal women age 50-64 years at increased short-term risk for osteoporotic fracture. Osteoporos Int (2007) 0.96
A differential effect of ethinyl estradiol upon plasma FSH and LH relating to time of administration in the menstrual cycle. J Clin Endocrinol Metab (1973) 0.96
New evidence for an anti-estrogenic action of clomiphene citrate in women. J Clin Endocrinol Metab (1971) 0.95
Enhanced immune response to leukaemia. Lancet (1971) 0.94
Human chorionic gonadotropin as a tumor marker. Ann Clin Lab Sci (1975) 0.94
HL-A and mixed leukocyte culture matched allogeneic bone marrow transplantation in patients with acute leukemia. Transplant Proc (1971) 0.93
Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia. J Clin Invest (1978) 0.92
Clinical implications of glucocorticoid receptors in human leukemia. Cancer Res (1978) 0.92
Long-term therapy of Paget's disease of bone with EHDP. Arthritis Rheum (1980) 0.92
Withdrawal bleeding and luteinizing hormone secretion following progesterone in women with amenorrhea. Am J Obstet Gynecol (1973) 0.92
Cisplatin therapy in recurrent childhood brain tumors. Cancer Treat Rep (1982) 0.92
Osteoporosis care at risk in the United States. Osteoporos Int (2008) 0.91
Gait analysis of patients who have Paget disease. J Bone Joint Surg Am (1989) 0.91
Efficacy of postoperative chemotherapy using cisplatin plus etoposide in young children with brain tumors. Med Pediatr Oncol (1991) 0.91
Lack of prognostic value of lymphoblast size in acute lymphoblastic leukaemia. Br J Haematol (1976) 0.90
Serum amyloid P-component levels in amyloidosis, connective tissue diseases, infection, and malignancy as compared to normal serum. J Lab Clin Med (1979) 0.90
The effect of lignocaine on PHA-stimulated human lymphocyte transformation. Br J Anaesth (1972) 0.90
Use of specific antisera to characterize biologic activity of hCG-beta subunit preparations. Endocrinology (1972) 0.90
Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B-cell type. Cancer (1993) 0.90
Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. J Clin Oncol (1991) 0.89
Neuroendocrine dysfunction in temporal lobe epilepsy. Arch Neurol (1982) 0.88
Immunologic and physical characterization of human chorionic gonadotropin (hCG) secreted by tumors. J Clin Endocrinol Metab (1973) 0.88
QT interval prolongation associated with anthracycline cardiotoxicity. J Pediatr (1984) 0.88
Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int (2012) 0.88
The challenges of peripheral bone density testing: which patients need additional central density skeletal measurements? J Clin Densitom (1998) 0.88
Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate. Ann Intern Med (1981) 0.87
Complication of bone-marrow transplantation. Graft-versus-host disease resulting from chronic-myelogenous-leukaemia leucocyte transfusions. Lancet (1970) 0.87
Appearance of hCG in pregnancy plasma following the initiation of implantation of the blastocyst. J Clin Endocrinol Metab (1975) 0.86
Specific radioimmunoassay of chorionic gonadotropin during implantation in rhesus monkeys. J Clin Endocrinol Metab (1974) 0.86
Large-cell calcifying sertoli cell tumor of the testis. An ultrastructural, immunocytochemical, and biochemical study. Cancer (1983) 0.86
Evidence for altered synthesis of human chorionic gonadotropin in gestational trophoblastic tumors. J Clin Endocrinol Metab (1976) 0.86
L-asparaginase toxicity. Cancer Res (1969) 0.86
Seeking the elusive etiology of Paget disease: a progress report. J Bone Miner Res (1996) 0.85
Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone. Calcif Tissue Int (1997) 0.85
Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial. Osteoporos Int (2011) 0.85
The influence of severe illness on gonadotropin secretion in the postmenopausal female. J Clin Endocrinol Metab (1977) 0.85
Effects of progressive desialylation on the rate of disappearance of immunoreactive HCG from plasma in rats. Endocrinology (1971) 0.85
Glucocorticoid receptors in lymphoid tumors. Cancer Res (1981) 0.85
With modern imaging techniques, is staging laparotomy necessary in pediatric Hodgkin's disease? A Pediatric Oncology Group study. J Clin Oncol (1993) 0.84
Immunocompetence following allogeneic bone marrow transplantation in man. Transplantation (1972) 0.84
New evidence for an acute role of protein kinase in hCG action. Endocrinology (1975) 0.84
Characterization of a small molecular size urinary immunoreactive human chorionic gonadotropin (hCG)-like substance produced by normal placenta and by hCG-secreting neoplasms. J Clin Endocrinol Metab (1981) 0.84
Recent advances in evaluation of gonadotropic hormones. Annu Rev Med (1973) 0.84
Exercise-induced menstrual dysfunction. Annu Rev Med (1988) 0.83
Premenstrual syndrome. N Engl J Med (1984) 0.83
The effect of daunomycin on human cells in vivo and in vitro. Cancer (1969) 0.83
Clinical and biochemical effects of EHDP in Paget's disease of bone: patterns of response to initial treatment and to long-term therapy. Metab Bone Dis Relat Res (1981) 0.83
Paget's disease of bone. Bull N Y Acad Med (1980) 0.83
Glucocorticoid receptors in subpopulations of childhood acute lymphocytic leukemia. Cancer Res (1977) 0.83
Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study. Osteoporos Int (2007) 0.82
A human myeloma immunoglobulin G binding four moles of calcium associated with asymptomatic hypercalcemia. J Clin Immunol (1984) 0.82
Immunologic basis for within and between species cross reactivity of luteinizing hormone. Endocrinology (1972) 0.82